Bluejay Diagnostics Shares Hit 52-Week Low After Public Offering Prices

Dow Jones06-27
 

By Chris Wack

 

Bluejay Diagnostics shares were down 50% to 82 cents, a 52-week low, after an underwritten public offering priced with proceeds expected to be about $8.75 million.

The stock closed Wednesday's session down 41%, and is now down 97% in the past 12 months.

The medical technology company said the base offering consists of 5.37 million units or prefunded units.

Each unit consists of one share of Bluejay stock or one pre-funded warrant, two class C warrants and one class D warrant. The purchase price of each unit was $1.63.

The closing of the offering is expected to occur Friday.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

June 27, 2024 10:08 ET (14:08 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment